Immunovaccine and Leidos are working together to determine the most promising malaria vaccine formulations.

Sanofi Pasteur has tapped Berg to learn more about biomarkers behind flu vaccine responses.

Johnson & Johnson and a U.S. development agency are zeroing in on pandemic flu in a novel deal focusing on vaccine and flu drug candidates.

GSK has formed an alliance with China’s e-commerce giant Alibaba to help promote HPV vaccine Cervarix.

Meissa Vaccines, a JLABS resident startup, has financial backing from the NIH and a VC firm to help advance its RSV vaccine candidate.

Valneva and Emergent BioSolutions will co-develop a Zika candidate slated to enter phase 1 in late 2017 or early 2018.

J&J's Janssen unit will shell out up to $879 million to develop HIV and HBV vaccines using Bavarian Nordic's MVA-BN technology.

Emergent BioSolutions has snapped up the only FDA-approved smallpox vaccine from Sanofi Pasteur.